Overview of Blood Pressure Changes in Hypertensive Patients using Valsartan at One of Hospital in Jember District

Rosyidatul Alvia Putri Priyono; Shinta Mayasari; Khrisna Agung C

Authors

Rosyidatul Alvia Putri Priyono Faculty of Health Sciences, University of Dr. Soebandi, Jl. Dr. Soebandi 99, Jember, Indonesia
Shinta Mayasari Faculty of Health Sciences, University of Dr. Soebandi, Jl. Dr. Soebandi 99, Jember, Indonesia
Khrisna Agung C Faculty of Health Sciences, University of Dr. Soebandi, Jl. Dr. Soebandi 99, Jember, Indonesia

Keywords:

Blood Pressure, Health, Hypertensions, Valsartan.

Abstract

Hypertension is a major global health issue contributing to cardiovascular disease, stroke, kidney failure, and premature death. Its prevalence continues to rise both globally and in Indonesia. Effective management often involves pharmacological treatment, with valsartan, an angiotensin II receptor blocker (ARB), widely used due to its efficacy and safety profile. This study aims to describe blood pressure changes in hypertensive patients treated with valsartan at one of hospital at Jember district. A descriptive observational study was conducted using medical records of patients receiving valsartan therapy from January to October 2022. A total of 4,907 patients were recorded, making hypertension one of the top ten most frequent diagnoses in the hospital. Results showed that valsartan effectively reduced both systolic and diastolic blood pressure, with most patients achieving target levels after treatment. These findings suggest that valsartan is effective in managing hypertension and preventing complications when properly administered and adhered to. Continued monitoring and appropriate treatment selection remain essential for optimal patient outcomes.

References

Artiyaningrum, B. (2016) ‘Faktor - Faktor yang Berhubungan dengan Kejadian Hipertensi Tidak Terkendali pada Penderita yang Melakukan Pemeriksaan Rutin’, Jurnal Perspektif Kesehatan Masyarakat, 1(1), pp. 12–20.

Kemenkes (2016) ‘Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016’, p. 5.

Kemenkes RI (2018) ‘Hasil Riset Kesehatan Dasar Tahun 2018’, Kementrian Kesehatan RI, 53(9), pp. 1689–1699.

Lisiswanti, R. and Dananda, D.N.A. (2016) ‘Hypertension Prevention Efforts’, Majority, 5(3), pp. 50–54 Availableat: https://juke.kedokteran.unila.ac.id/index.php/majority/article/view/1036.

Mayasari, S. (2020) ‘Analysis Of The Used Of Captopril Drug With Blood

Pressure Of Hypertension Patients’, Jurnal Kesehatan dr. Soebandi, 8(2), pp. 123–127. Available at: https://doi.org/10.36858/jkds.v8i2.225.

Mubin, A.H. and Mubin, R.H. (2016) ‘Panduan Praktis Ilmu Penyakit Dalam: Diagnosis dan Terapi Edisi 3’, Jakarta: EGC [Preprint].

Musnelina, L., & Yanti, S. E. N. K. (2020). Evaluasi penggunaan obat antihipertensi pada pasien hipertensi primer di Rumah Sakit Umum Daerah Kota Depok. Sainstech Farma: Jurnal Ilmu Kefarmasian, 10(1), 8–12.

Narkiewicz, K., Niiranen, T., et al. (2018). 2018 ESC/ESH Guidelines for themanagement of arterial hypertension. European Heart Journal.

Notoatmodjo, S. (2018) ‘Metodologi Penelitian Kesehatan Cetakan ke-3’, Pt Rineka Cipta [Preprint].

Nugroho, A.E. (2012) Farmakologi: obat-obat penting dalam pembelajaran ilmu farmasi dan dunia kesehatan. Pustaka Pelajar.

Nursalam, N. (2019) Konsep dan Penerapan Metodologi Penelitian Ilmu Keperawatan (87). Stikes Perintis Padang.

Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (2015) ‘Pedoman Tatalaksana Hipertensi pada Penyakit Kardiovaskular’, Physical Review D [Preprint].

Prayitnaningsih, S., Rohman, M. S., Sujuti, H., Abdullah, A. A. H., & Vierlia, W. V. (2021). Pengaruh Hipertensi Terhadap Glaukoma. Universitas Brawijaya

Priantoro, H. (2018) ‘Hubungan Beban Kerja Dan Lingkungan Kerja Dengan Kejadian Burnout Perawat Dalam Menangani Pasien Bpjs’, Jurnal Ilmiah Kesehatan, 16(3), pp. 9–16.

Rahmadhani, M. (2021). Faktor-faktor yang mempengaruhi terjadinya hipertensi pada masyarakat di Kampung Bedagai Kota Pinang (The factors that affecting hypertension in Bedagai Village, Kota Pinang society). Jurnal Kedokteran STM (Sains dan Teknologi Medik), IV(1). https://ojsfkuisu.com/index.php/stm/index

Rijali, A. (2019) ‘Analisis Data Kualitatif’, Alhadharah: Jurnal Ilmu Dakwah, 17(33), p. 81.

Ristatianti, Silvi., Chaerunissa, Yohana Anis. (2018). Review: Pengembangan Valsartam dalam Meningkatkan Kelarutan dan Bioavailabilitas dalam Tubuh. Farmaka, 17.1

Sugiyono, D. (2019) ‘Statistika untuk Penelitian (Cetakan ke-30)’, Bandung: Cv Alfabeta [Preprint].

Whelton, P. K., & Williams, B. (2018, November 6). The 2018 European Society of Cardiology/European Society of Hypertension and 2017 American College of Cardiology/American Heart Association blood pressure guidelines: More similar than different. JAMA, 320(17), 1749–1750. https://jamanetwork.com/journals/jama/article-abstract/2712552.

Yanita, N.I.S. (2022) Berdamai dengan Hipertensi. Bumi Medika.